Literature DB >> 10900225

Functional compartmentalization of opioid desensitization in primary sensory neurons.

G M Samoriski1, R A Gross.   

Abstract

The cellular correlates of desensitization or tolerance are poorly understood. To address this, we studied acute and long-term mu-opioid desensitization, with respect to Ca(2+) currents, in cultured rat dorsal root ganglion (DRG) neurons. Exposure of DRG neurons to the mu-agonist [D-Ala(2),N-MePhe(4), Gly-ol(5)]-enkephalin (DAMGO; 3 microM) reduced whole-cell currents approximately 35%, but with continued agonist application, 52% of the response was lost over 10 to 12 min. In contrast, exposure of DRG neurons to DAMGO for 24 h resulted in a nearly complete loss of Ca(2+) channel regulation after washing and re-exposure to DAMGO. Responses to the gamma-aminobutyric acid(B) agonist baclofen were not affected in these neurons. Acute desensitization preferentially affected the voltage-sensitive component of mu-opioid and gamma-aminobutyric acid(B) responses. Facilitation of both the DAMGO- and baclofen-inhibited current by a strong depolarizing prepulse was significantly attenuated in acutely desensitized neurons. Because G(betagamma)-subunits mediate neurotransmitter-induced changes in channel voltage-dependent properties, these data suggest an altered interaction of the G(betagamma)-subunit with the Ca(2+) channel. Block of N-type Ca(2+) channels with omega-conotoxin GVIA revealed a component of the opioid response that did not desensitize over 10 min. We conclude that acute and long-term mu-opioid desensitization in DRG neurons occurs by different mechanisms. Acute desensitization is heterologous and functionally compartmentalized: the pathway targeting non-N-type channels is relatively resistant to the early effects of continuous agonist exposure; the pathway targeting N-type channels in a largely voltage-insensitive manner is partially desensitized; and the pathway targeting N-type channels in a largely voltage-sensitive manner is completely desensitized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900225

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors.

Authors:  J K Scott; S F Huang; B P Gangadhar; G M Samoriski; P Clapp; R A Gross; R Taussig; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 2.  Mu-opioid receptor desensitization: is morphine different?

Authors:  Mark Connor; Peregrine B Osborne; MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2004-10-25       Impact factor: 8.739

3.  Muscarinic acetylcholine receptor modulation of mu (mu) opioid receptors in adult rat sphenopalatine ganglion neurons.

Authors:  Wojciech Margas; Saifeldin Mahmoud; Victor Ruiz-Velasco
Journal:  J Neurophysiol       Date:  2009-11-04       Impact factor: 2.714

4.  Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Authors:  Kelly A Berg; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; Amol M Patwardhan; Stephen B Milam; Kenneth M Hargreaves; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2011-04-12       Impact factor: 4.030

5.  Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.

Authors:  Emma E Johnson; Billy Chieng; Ian Napier; Mark Connor
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

6.  Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Authors:  M Fantin; C Fischetti; C Trapella; M Morari
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.